Composition comprising material for regulating oct4 modification to repress stemness
AssigneeNational Cancer Center
InventorsHyonchol JANG, Dong Keon KIM
Life of this patent
Estimating the term…
Loading patent…
AssigneeNational Cancer Center
InventorsHyonchol JANG, Dong Keon KIM
Estimating the term…
The present invention relates to a composition for repressing the sternness of stem cells, which comprises a material for regulating OCT4 modification. The material for regulating OCT4 modification according to the present invention may regulate the phosphorylation or methylation of OCT4 and inhibit Wnt signaling, thereby effectively reducing the sternness of various stem cells. Therefore, since it can be effectively used in inhibition of proliferation, recurrence and metastasis of cancer, and inhibition of resistance to an anticancer agent, and can reduce sternness even in normal stem cells, it is expected that the time for differentiation of embryonic stem cells into specific cells is shortened, and efficiency is increased.
A method of inhibiting stemness through regulation of OCT4 modification in vitro, comprising any one or mere selected from the group consisting of the following:
A method of regulating stemness through regulation of the function of OCT4 modification in vitro, comprising:
An antibody for detecting whether serine 351 in the amino acid sequence of mouse octamer-binding transcription factor 4 (OCT4) or serine 359 in the amino acid sequence of human OCT4 is phosphorylated,
A method of screening a material for repressing the stemness of stem cells, comprising:
A method of diagnosing whether the stemness of stem cells is repressed, comprising:
12-29. (canceled)
Dependencies are inferred from the claim text.